Statistics

Total Visits

Views
Pharmacoeconomic evaluation of tocilizumab monotherapy versus adalimumab monotherapy in reducing disease activity in patients with rheumatoid arthritis52

Select a period of time:

Number of views in the range

Views
Pharmacoeconomic evaluation of tocilizumab monotherapy versus adalimumab monotherapy in reducing disease activity in patients with rheumatoid arthritis15

Views

Views
October 20250
November 20252
December 20253
January 20261
February 20263
March 20266
April 20260
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States6
Argentina3
Ecuador2
Australia1
Finland1
Kenya1
South Africa1
 

Top cities views

Views
Quito2
Boca Toma1
Grand Bourg1
Helsinki1
Nairobi1
San Salvador de Jujuy1
Santa Clara1
Surprise1